Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · May 27, 2026
Lymph node stromal topology as a hidden regulator of breast cancer outcome: commentary on reticular network analysis(†).
Read at PubMed CentralPubMed Central · May 25, 2026
Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type.
Read at PubMed CentralPubMed Central · May 24, 2026
Desmoplasia and therapeutic resistance in pancreatic ductal adenocarcinoma.
Read at PubMed CentralPubMed Central · May 22, 2026
HOXB13, a high-risk prostate cancer gene, also confers risk for breast cancer: novel variants of clinical significance, especially in hormone-positive patients.
Read at PubMed CentralPubMed Central · May 22, 2026
First-Line Systemic Treatments of Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-Analysis.
Read at PubMed CentralPubMed Central · May 22, 2026
Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma With SQSTM1::ALK Fusion.
Read at PubMed CentralPubMed Central · May 20, 2026
Gastric Cancer-Derived Exosomal MATN3 Favours Immunosuppressive Tumour Microenvironment by Activating Autophagy in an EGFR/ELK1/ATG12 Signalling Dependent Manner.
Read at PubMed CentralPubMed Central · May 20, 2026
Diagnostic Prediction Models for Depression in Patients With Breast Cancer: A Systematic Review.
Read at PubMed CentralPubMed Central · May 20, 2026
Urine Tumor DNA Testing Identifies Recurrence and Monitors Therapy Response in Patients With High-Risk Nonmuscle-Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin.
Read at PubMed CentralPubMed Central · May 20, 2026
Definitive radiotherapy for non-small-cell lung cancer: current practice and future directions.
Read at PubMed CentralPubMed Central · May 20, 2026
Characteristics of ill-demarcated small pancreatic ductal adenocarcinoma on MRI: a multi-institutional retrospective cohort study.
Read at PubMed CentralPubMed Central · May 18, 2026
Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy Plus Bacillus Calmette-Guérin for High-Risk Nonmuscle-Invasive Bladder Cancer: Analyses of CREST, POTOMAC, and ALBAN.
Read at PubMed CentralPubMed Central · May 15, 2026
MRI Habitat Analysis for Preoperative Prediction of Perineural Invasion and Prognostic Stratification in Rectal Cancer.
Read at PubMed CentralPubMed Central · May 13, 2026
The underexplored complexity of pancreatic cancer: Early dissemination and quiescence.
Read at PubMed CentralPubMed Central · May 13, 2026
Management of skin metastases of ovarian cancer: a novel therapeutic approach.
Read at PubMed CentralPubMed Central · May 12, 2026
Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trial.
Read at PubMed CentralNational Cancer Institute · May 6, 2026
NIH-funded study suggests that testosterone suppresses brain tumor growth in males
In a new National Institutes of Health (NIH)-funded study, scientists at Cleveland Clinic discovered that hormones associated with male development may play a key role in limiting the growth of brain tumors in men. The research team found that the loss of androgen hormones, such as testosterone, in a preclinical model of glioblastoma drove tumor growth by inducing local inflammation and triggering the production of stress hormones.
View original at National Cancer InstitutePubMed Central · May 6, 2026
High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases.
Read at PubMed CentralPubMed Central · May 4, 2026
Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression.
Read at PubMed CentralPubMed Central · May 1, 2026
Blockade of Tumor TAK1 Induces DNA Damage and Immunogenic cGAS-STING Pathway Activation in Pancreatic Cancer.
Read at PubMed Central